Related Experiment Videos
Two-stage designs for gene-disease association studies
Jaya M Satagopan1, David A Verbel, E S Venkatraman
1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. satago@biosta.mskcc.org
Biometrics
|March 14, 2002
Summary
This study introduces a cost-effective two-stage design for detecting gene-disease associations. Screening all markers on a subset of individuals first maximizes statistical power while minimizing gene evaluation costs.
Area of Science:
- Genetics
- Biostatistics
- Bioinformatics
Background:
- Gene-disease association studies are crucial for understanding complex traits.
- Traditional study designs can be resource-intensive, limiting the number of genes evaluated.
- Optimizing cost-efficiency is essential for maximizing the power of genetic association studies.
Purpose of the Study:
- To describe a novel two-stage design for gene-disease association studies.
- To maximize statistical power under a total cost constraint, defined by gene evaluations.
- To provide a cost-effective strategy for genetic marker screening.
Main Methods:
- A two-stage design involving initial screening of all genes on a subset of individuals.
- Subsequent evaluation of promising genes on additional subjects in a second stage.
- Consideration of both independent and correlated gene scenarios.
- Simulation studies to evaluate design performance.
Main Results:
- A two-stage approach effectively eliminates wasted resources on genes unlikely to be associated with disease.
- Utilizing 75% of resources in stage 1 to screen all markers and the remaining 25% to evaluate the top 10% of markers offers near-optimal power.
- This strategy is effective for both independent and small-correlation gene scenarios.
- Stage 1 involves screening all markers on approximately one quarter of the total sample size.
Conclusions:
- The proposed two-stage design offers a powerful and cost-efficient method for gene-disease association studies.
- The general guideline of screening all markers on a subset (approx. 25% of sample size) and re-evaluating top markers (approx. 10%) is robust across various configurations.
- This approach significantly enhances the efficiency of genetic association studies by optimizing resource allocation.